Core A, the Administrative Core of this National Institute of Neurological Disorders and Stroke (NINDS) Morris K. Udall Parkinson's Disease Research Center of Excellence (Udall Center) at the University of Pennsylvania (Penn), will facilitate accomplishing the goals of this multidisciplinary research program. Briefly, the goals of this Udall Center are to elucidate mechanisms of progressive neurodegeneration in Parkinson's disease (PD), especially those mechanisms underlying the cognitive and executive impairments in PD patients without and with dementia (PDD) and in dementia with Lewy bodies (DLB) patients. We hypothesize that disease progression leads to neuron dysfunction and death resulting from the differential transmission of pathologic alpha-synuclein species or strains and their neurotoxic effects in patients with PD/PDD/DLB. Thus, the Aims of Core A are to oversee budgetary and fiscal aspects of this Udall Center;promote and foster interactions between Core and Project investigators, as well as interactions of Udall Center investigators with scientists outside the Center at and beyond Penn;monitor the progress of the Cores and Projects;facilitate the sharing of data, reagents, and resources generated by Penn Udall Center investigators with other researchers in accordance with NIH policies;and participate in annual Udall Center meetings to accelerate the pace of advances in understanding PD/PDD/DLB. By utilizing the strategies in these Aims, Core A will play an important administrative role in this Udall Center by fostering the accomplishment of its overall mission..
Core A is highly relevant to the mission of the Penn Udall Center because it supports the efforts of each of the Cores and Projects in the Center to challenge and re-define current understanding of and research on PD/PDD/DLB by implementing the Specific Aims of Core A.
|Tropea, Thomas F; Xie, Sharon X; Rick, Jacqueline et al. (2017) APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease. Mov Disord :|
|Schrag, Anette; Siddiqui, Uzma Faisal; Anastasiou, Zacharias et al. (2017) Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study. Lancet Neurol 16:66-75|
|Cousins, Katheryn A Q; Ash, Sharon; Grossman, Murray (2017) Production of verbs related to body movement in amyotrophic lateral sclerosis (ALS) and Parkinson's Disease (PD). Cortex :|
|Rennert, Lior; Xie, Sharon X (2017) Cox regression model with doubly truncated data. Biometrics :|
|St John-Williams, Lisa; Blach, Colette; Toledo, Jon B et al. (2017) Targeted metabolomics and medication classification data from participants in the ADNI1 cohort. Sci Data 4:170140|
|Ash, Sharon; Jester, Charles; York, Collin et al. (2017) Longitudinal decline in speech production in Parkinson's disease spectrum disorders. Brain Lang 171:42-51|
|Lopez, Alexander M; Weintraub, Daniel; Claassen, Daniel O (2017) Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy. Semin Neurol 37:186-192|
|Akhtar, Rizwan S; Xie, Sharon X; Chen, Yin J et al. (2017) Regional brain amyloid-? accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia. PLoS One 12:e0177924|
|Cooper, Christine A; Jain, Nimansha; Gallagher, Michael D et al. (2017) Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype. Ann Clin Transl Neurol 4:15-25|
|Rutten, Sonja; Vriend, Chris; van der Werf, Ysbrand D et al. (2017) The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's disease. Parkinsonism Relat Disord 39:31-36|
Showing the most recent 10 out of 301 publications